These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33724254)

  • 1. Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial.
    Farajollahi-Moghadam M; Sanjari-Moghaddam H; Ghazizadeh Hasemi M; Sanatian Z; Talaei A; Akhondzadeh S
    Int Clin Psychopharmacol; 2021 May; 36(3):140-146. PubMed ID: 33724254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
    El-Haggar SM; Eissa MA; Mostafa TM; El-Attar KS; Abdallah MS
    Psychother Psychosom; 2018; 87(6):331-339. PubMed ID: 30205379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Shamabadi A; Kafi F; Arab Bafrani M; Asadigandomani H; A Basti F; Akhondzadeh S
    J Affect Disord; 2023 Jul; 333():38-43. PubMed ID: 37084960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline treatment of major depression in patients with acute MI or unstable angina.
    Glassman AH; O'Connor CM; Califf RM; Swedberg K; Schwartz P; Bigger JT; Krishnan KR; van Zyl LT; Swenson JR; Finkel MS; Landau C; Shapiro PA; Pepine CJ; Mardekian J; Harrison WM; Barton D; Mclvor M;
    JAMA; 2002 Aug; 288(6):701-9. PubMed ID: 12169073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial.
    Borhannejad F; Shariati B; Naderi S; Shalbafan M; Mortezaei A; Sahebolzamani E; Saeb A; Hosein Mortazavi S; Kamalzadeh L; Aqamolaei A; Ali Noorbala A; Namazi-Shabestari A; Akhondzadeh S
    J Clin Pharm Ther; 2020 Aug; 45(4):804-811. PubMed ID: 32420649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting: A randomized, double-blind, placebo-controlled trial.
    Yasrebi SO; Momtazmanesh S; Moghaddam HS; Shahmansouri N; Mehrpooya M; Arbabi M; Ghazizadeh-Hashemi F; Akhondzadeh S
    J Psychosom Res; 2021 Nov; 150():110635. PubMed ID: 34627009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial.
    Khadivi A; Shobeiri P; Momtazmaneh S; Samsami FS; Shalbafan M; Shirazi E; Akhondzadeh S
    Psychopharmacology (Berl); 2022 Feb; 239(2):551-559. PubMed ID: 35072758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Merza Mohammad TA; Merza Mohammad TA; Salman DM; Jaafar HM
    Pharmacopsychiatry; 2024 Jul; 57(4):205-214. PubMed ID: 38710206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    ; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
    JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial.
    Gao L; Wu C; Liao Y; Wang J
    J Affect Disord; 2020 Mar; 265():99-103. PubMed ID: 32090788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind comparison of aripiprazole/sertraline combination and placebo/sertraline combination in patients with major depressive disorder.
    Kamijima K; Kimura M; Kuwahara K; Kitayama Y; Tadori Y
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):591-601. PubMed ID: 29660207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for Anti-inflammatory Effects of Adalimumab in Treatment of Patients With Major Depressive Disorder: A Pilot, Randomized, Controlled Trial.
    Abbasian F; Bagheri S; Moradi K; Keykhaei M; Etemadi A; Shalbafan M; Shariati B; Vaseghi S; Samsami FS; Akhondzadeh S
    Clin Neuropharmacol; 2022 Sep-Oct 01; 45(5):128-134. PubMed ID: 36093920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study.
    Amidfar M; Khiabany M; Kohi A; Salardini E; Arbabi M; Roohi Azizi M; Zarrindast MR; Mohammadinejad P; Zeinoddini A; Akhondzadeh S
    J Clin Pharm Ther; 2017 Feb; 42(1):44-50. PubMed ID: 27809351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.
    Garlow SJ; Dunlop BW; Ninan PT; Nemeroff CB
    J Psychiatr Res; 2012 Nov; 46(11):1406-13. PubMed ID: 22964160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Hoobehfekr S; Moghaddam HS; Shalbafan M; Hashemi MG; Pirmoradi MM; Sakenian A; Poopak A; Kashefinejad S; Yarahmadi M; Akhondzadeh S
    Psychiatry Clin Neurosci; 2021 Feb; 75(2):57-62. PubMed ID: 33247483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial.
    Ghazizadeh-Hashemi M; Ghajar A; Shalbafan MR; Ghazizadeh-Hashemi F; Afarideh M; Malekpour F; Ghaleiha A; Ardebili ME; Akhondzadeh S
    J Affect Disord; 2018 May; 232():127-133. PubMed ID: 29486338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.